Fingerprint
Dive into the research topics of 'The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug, Dalane W. Kitzman, Sanjiv J. Shah, Fengming Tang, Yevgeniy Khariton, Ali O. Malik, Taiyeb Khumri, Guillermo Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S. Khan, Lokesh Chandra, Robert A. Gordon, John J. Ryan, Sunit Preet Chaudhry, Susan M. Joseph, Chen H. Chow, Manreet K. Kanwar
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
371
Scopus
citations